import {
  ResourceArticleTemplate,
  type ResourceArticle,
} from "../../../components/site/ResourceArticleTemplate";
import { getArticleSources } from "../../../lib/articleSources";
import { buildArticleMetadata } from "../../../lib/seo";

export const dynamic = "force-static";

const article: ResourceArticle = {
  path: "/resources/sector-specific-procurement-dynamics-in-healthcare",
  title: "Sector-Specific Procurement Dynamics in Healthcare",
  description:
    "A guide to healthcare procurement dynamics, including regulatory assurance, clinical evidence, frameworks, supplier concentration, and procurement intelligence signals.",
  publishedAt: "2026-03-14T00:00:00+00:00",
  publishedLabel: "March 2026",
  modifiedAt: "2026-04-25T00:00:00+00:00",
  modifiedLabel: "April 2026",
  answer:
    "Healthcare procurement is shaped by clinical risk, regulatory assurance, patient safety, supply continuity, framework purchasing, and specialist evaluation criteria. Suppliers need to prepare evidence earlier because procurement decisions often depend on safety, efficacy, compliance, lifecycle cost, and stakeholder trust, not price alone.",
  intro: (
    <>
      <p className="article-body-text">
        Healthcare procurement sits at the intersection of public purchasing,
        clinical governance, regulation, and operational resilience. A supplier
        may satisfy a commercial requirement but still face hurdles around
        safety, evidence, certification, interoperability, or supply continuity.
      </p>
      <p className="article-body-text">
        That makes healthcare a sector where procurement intelligence needs to
        read more than tender notices. Regulatory developments, framework
        renewals, health technology assessment, shortage risk, and clinical
        adoption patterns can all shape future demand.
      </p>
    </>
  ),
  takeaways: [
    {
      label: "Assurance",
      text: "Healthcare buyers need evidence that protects safety, continuity, and clinical outcomes.",
    },
    {
      label: "Frameworks",
      text: "Recurring healthcare categories often rely on multi-year panels, lots, and call-off structures.",
    },
    {
      label: "Signals",
      text: "Regulatory approvals, HTA activity, and renewal windows can precede procurement demand.",
    },
  ],
  civantView: {
    title: "Healthcare procurement rewards evidence prepared before the notice.",
    content: (
      <p>
        In healthcare markets, late preparation is especially costly. Suppliers
        need clinical, regulatory, operational, and commercial proof ready before
        a buyer asks for it under deadline pressure.
      </p>
    ),
  },
  sections: [
    {
      id: "regulatory-and-clinical-context",
      title: "Regulatory And Clinical Context",
      content: (
        <>
          <p className="article-body-text">
            Healthcare purchasing can involve medical device rules, medicine
            availability considerations, health technology assessment, clinical
            governance, data protection, and patient-safety obligations. These
            layers make category expertise essential.
          </p>
          <p className="article-body-text">
            Procurement teams may evaluate not only price and compliance, but
            also evidence of outcomes, safety, usability, interoperability,
            training, implementation risk, and continuity of supply.
          </p>
        </>
      ),
    },
    {
      id: "framework-and-supply-patterns",
      title: "Framework And Supply Patterns",
      content: (
        <>
          <p className="article-body-text">
            Many healthcare categories use frameworks, dynamic purchasing
            systems, central purchasing bodies, and multi-lot structures to
            manage recurring demand and reduce administrative burden.
          </p>
          <p className="article-body-text">
            These structures can create stable supplier relationships, but they
            also make timing critical. Missing a framework window can limit
            access until the next renewal or reopening point.
          </p>
        </>
      ),
    },
    {
      id: "supplier-entry-barriers",
      title: "Supplier Entry Barriers",
      content: (
        <>
          <p className="article-body-text">
            New entrants often need more than a compliant product or service.
            They need references, regulatory evidence, integration proof,
            implementation support, and confidence that their solution will not
            disrupt clinical or operational continuity.
          </p>
          <p className="article-body-text">
            Differentiation usually depends on measurable value: improved
            outcomes, lower lifecycle cost, reduced staff burden, stronger
            resilience, or better user experience for clinicians and patients.
          </p>
        </>
      ),
    },
    {
      id: "healthcare-intelligence",
      title: "Healthcare Intelligence",
      content: (
        <>
          <p className="article-body-text">
            Healthcare procurement intelligence should monitor framework
            expiries, award history, clinical policy changes, technology
            approvals, supply-risk signals, and buyer investment priorities.
          </p>
          <p className="article-body-text">
            The goal is to understand when a buyer may be open to change, what
            evidence will be required, and which partners or references should
            be prepared before the formal process begins.
          </p>
        </>
      ),
    },
  ],
  action: {
    eyebrow: "Next Step",
    title: "Bring healthcare procurement signals into earlier account planning.",
    primaryHref: "/platform",
    primaryLabel: "Explore Platform",
    secondaryHref: "/contact",
    secondaryLabel: "Talk To Civant",
  },
  faqs: [
    {
      question: "Why is healthcare procurement complex?",
      answer:
        "Healthcare procurement must account for clinical safety, regulatory evidence, supply continuity, implementation risk, patient outcomes, and public procurement rules at the same time.",
    },
    {
      question: "What signals matter in healthcare procurement intelligence?",
      answer:
        "Useful signals include framework renewal dates, medical device regulation, health technology assessment activity, clinical policy changes, supply-risk alerts, and buyer investment priorities.",
    },
    {
      question: "How can suppliers differentiate in healthcare tenders?",
      answer:
        "They can differentiate with evidence of outcomes, safety, interoperability, implementation support, lifecycle value, resilience, and strong references in comparable environments.",
    },
  ],
  sources: getArticleSources([
    "europeanCommissionMedicalDevices",
    "europeanCommissionHealthTechnologyAssessment",
    "eurLexDirective201424",
    "europeanCommissionPublicProcurement",
  ]),
  relatedSolution: {
    solutionSlug: "public-procurement-intelligence",
    linkLabel: "Explore public procurement intelligence",
    children:
      "See how Civant helps teams connect sector signals, buyer cycles, and procurement evidence before formal tender windows.",
  },
};

export const metadata = buildArticleMetadata({
  title: article.title,
  description: article.description,
  path: article.path,
  datePublished: article.publishedAt,
  dateModified: article.modifiedAt,
});

export default function ArticlePage() {
  return <ResourceArticleTemplate article={article} />;
}
